Treatment of postanoxic intention myoclonus with valproic acid.
作者： J. Bruni , L.J. Willmore , B.J. Wilder
DOI: 10.1017/S0317167100119341
关键词:
摘要: Valproic acid in therapeutic doses was used the treatment of postanoxic intention myoclonus. Disappearance myoclonus occurred with marked improvement electroencephalogram. No significant side effects were noted. Hepatic function tests monitored. Determination valproic plasma levels to guide therapy. Levels above 55 micrograms generally required. The patient remains free after four and one half months.
sci-hub.se 参考文章(22)
JAMES W. LANCE, RAYMOND D. ADAMS, THE SYNDROME OF INTENTION OR ACTION MYOCLONUS AS A SEQUEL TO HYPOXIC ENCEPHALOPATHY Brain. ,vol. 86, pp. 111- 136 ,(1963) , 10.1093/BRAIN/86.1.111
P.K.P. Harvey, H.F. Bradford, A.N. Davison, The inhibitory effect of sodium n-dipropyl acetate on the degradative enzymes of the GABA shunt. FEBS Letters. ,vol. 52, pp. 251- 254 ,(1975) , 10.1016/0014-5793(75)80817-9
C. Guilleminault, B.R. Tharp, D. Cousin, HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements Journal of the Neurological Sciences. ,vol. 18, pp. 435- 441 ,(1973) , 10.1016/0022-510X(73)90137-8
Genjiio Hirose, Successful Treatment of Posthypoxic Action Myoclonus With Carbamazepine JAMA: The Journal of the American Medical Association. ,vol. 218, pp. 1432- 1433 ,(1971) , 10.1001/JAMA.1971.03190220050017
M. H. VAN WOERT, V. H. SETHY, Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Neurology. ,vol. 25, pp. 135- 135 ,(1975) , 10.1212/WNL.25.2.135
H. J. Villarreal, B. J. Wilder, L. J. Willmore, A. W. Bauman, E. J. Hammond, J. Bruni, Effect of valproic acid on spike and wave discharges in patients with absence seizures Neurology. ,vol. 28, pp. 886- 886 ,(1978) , 10.1212/WNL.28.9.886
T. L. Perry, K. Berry, S. Hansen, S. Diamond, C. Mok, Regional distribution of amino acids in human brain obtained at autopsy. Journal of Neurochemistry. ,vol. 18, pp. 513- 519 ,(1971) , 10.1111/J.1471-4159.1971.TB11979.X
I. Sherwin, W. Redmon, Successful treatment in action myoclonus Neurology. ,vol. 19, pp. 846- 846 ,(1969) , 10.1212/WNL.19.9.846
Roger W. Horton, Gill M. Anlezark, M.Christina B. Sawaya, Brian S. Meldrum, Monoamine and GABA metabolism and the anticonvulsant action of DI-n-propylacetate and ethanolamine-O-sulphate European Journal of Pharmacology. ,vol. 41, pp. 387- 397 ,(1977) , 10.1016/0014-2999(77)90259-X
Melvin H. Van Woert, David Rosenbaum, John Howieson, Malcolm B. Bowers, Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa New England Journal of Medicine. ,vol. 296, pp. 70- 75 ,(1977) , 10.1056/NEJM197701132960203